MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $27.200 million which beat the analyst consensus estimate of $25.884 million by 5.08 percent. This is a 2.24 percent increase over sales of $26.605 million the same period last year.